References
- Chaulin AM, Duplyakov DV. Increased natriuretic peptides not associated with heart failure. Russ. J. Cardiol. 2020;25:4140.
- Cao Z, Jia Y, Zhu B. BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine. Int J Mol Sci. 2019;20(8):1820
- Tofler G, Kopel E, Klempfner R, Eldar M, Buckley T, Goldenberg I. Triggers and timing of acute coronary syndrome. Coronary artery dis. 2017;119(10): p1560-5.
- Pimple P, Lima B, Hammadah M, Wilmot K, Ramadan R, Leventsevych, et al. Psychological Distress and Subsequent Cardiovascular Events in Individuals With Coronary Artery Disease. Am Heart J. 2019;8:e011866
- Wouters LT, Zwart DL, Erkelens DC, Cheung NS, de Groot E, Damoiseaux RA, et al. Chest discomfort at night and risk of acute coronary syndrome: cross-sectional study of telephone conversations. Fam Pract. 2020;37(4):473-478.
- Berge K, Brynildsen J, Røysland R, Strand H, Christensen G, Høiseth AD, et al. Prognostic value of cardiac biomarkers and National Early Warning Score 2 in acute dyspnoea. Open Heart. 2022;9(1):e001938.
- Rahmani R, Shafiee A, Parazaran K, Reshadati N. Predictive value of N-terminal-Pro brain natriuretic peptide in the detection of coronary artery disease in patients with positive myocardial perfusion imaging. Med J Islam Repub Iran. 2019;33:14.
- Gupta A, Beig JR, Tramboo NA, Afroze D, Hafeez I, Rather HA. The effect of percutaneous coronary revascularization on plasma N-terminal pro-B-type natriuretic peptide levels in stable coronary artery disease. Indian Heart J. 2018;70(2):282-288.
- Salama RH, El-Moniem AE, El-Hefney N, Samor T. NTerminaL PRO-BNP in Acute Coronary Syndrome Patients with ST Elevation Versus Non ST Elevation in Qassim Region of Saudi Arabia. Int J Health Sci (Qassim). 2011;5(2):136-45.
- Sterling MR, Durant RW, Bryan J, Levitan E, Brown T, Khodneva Y, et al. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study. BMC Cardiovasc Disord 2018;18:66.
- Sarak T, Karadeniz M.The relationship between serum NT-proBNP levels and severity of coronary artery disease assessed by SYNTAX score in patients with acute myocardial infarction. Turk J Med Sci. 2019;49:1366-1373
- Goetze JP, Gore A, Møller CH, Steinbrüchel DA, Rehfeld JF, Nielsen LB. Acute myocardial hypoxia increases BNP gene expression. FASEB J. 2004;18(15):1928-30.
- WeidmannA, Klanke B, Wagner M, Volk T, Willam C, Wiesener MS, et al. Hypoxia, via stabilization of the hypoxia- inducible factor HIF-1α, is a direct and sufficient stimulus for brain-type natriuretic peptide inductionBiochem. J. 2008; 409 (233–242)
- Jarai R, Kaun C, Weiss TW, Speidi W, Richi K, Maurer G, et al. Human cardiac fibroblasts express Btype natriuretic peptide: fluvastatin ameliorates its upregulation by interleukin-1alpha, tumor necrosis factoralpha and transforming growth factor-beta. J. Cell. Mol. Med. 2013; 13(11-12):4415-21
- Arjamaa O, Nikinmaa M. Hypoxia regulates the natriuretic peptide system. Int. J. Physiol. Pathophysiol. Pharmacol. 2011;3:191–201.
- Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ et al. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698-717
- Rautureau Y, Baxter GF. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium. Curr Pharm Des. 2004;10(20):2477-82.
- Kurt IH, Batur MK, Unal I. The effect of streptokinase therapy in STEMI and conventional therapy in NSTEMI patients on TIMI risk index, B-type natriuretic peptide and high-sensitive C-reactive protein. Anatol. J. Cardiol. 2011; 11(6):530-5.
- Ogawa A, Seino Y, Yamashita T, Ogata K, Takano T. Difference in elevation of N-terminal pro-BNP and conventional cardiac markers between patients with ST elevation vs non-ST elevation acute coronary syndrome. Circ J. 2006;70(11):1372-8.
- Drewniak W, Snopek G, Zarukiewicz M, Borys M, Dabrowski M. Prognostic value of the N-terminal pro- B-type natriuretic peptide in the elderly with acute myocardial infarction. Kardiol Pol. 2008; 66(7): 750-7.
- Buchner S, Debl K, Barlage S, Griese D, Fredersdorf S, Jeron A,et al. Dynamic changes in N-terminal pro-brain natriuretic peptide in acute coronary syndromes treated with percutaneous coronary intervention: a marker of ischemic burden, reperfusion and outcome. Clin Chem Lab Med. 2010; 48:875–81.
- Mathbout M, Asfour A, Leung S, Lolay G, Idris A, Abdel-Latif A, Ziada KM. NT-proBNP Level Predicts Extent of Myonecrosis and Clinical Adverse Outcomes in Patients with ST-Elevation Myocardial Infarction: A Pilot Study. Med Res Arch. 2020;8(2):10.18103/mra.v8i2.2039.
- Fabris E, Ten Berg JM, Hermanides RS, Ottervanger JP, Dambrink JHE, Gosselink AM, et al. NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: Insight from the On-TIME II trial. Am Heart J. 2021;233:78-85
- Marjanovic D, Miljkovic J, Stanetic B. Assessment of Prognostic Markers of Heart Failure Following Acute Myocardial Infarction in Patients Treated With Primary Percutaneous Coronary Intervention. Scr Med 2022;53(2):125-9
- Redfors B, Chen S, Crowley A, Ben-Yehuda O, Gersh BJ, Lembo NJ, et al. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Circulation. 2018;138(5):469-478.
- Neyou A, O’Neil B, Berman AD, Boura JA, McCullough PA. et al. Determinants of markedly increased B-type natriuretic peptide in patients with STsegment elevation myocardial infarction. Am J Emerg Med. 2011; 29(2): 141–7.
- Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, et al. Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am CollCardiol. 2007; 49(1):109-16.